This review summarizes recent evidence on psychological treatments for eating disorders.
INTRODUCTION
This review discusses evidence-based psychological treatments for anorexia nervosa, bulimia nervosa, binge eating disorder, and subclinical diagnoses, with a focus on clinical research updates from the past 18 months. Future directions for eating disorder treatment research are provided, including strategies to increase the potency, dissemination, and implementation of evidence-based treatments.
TREATMENT FOR ADULTS
Updates on treatments for adults with anorexia nervosa, bulimia nervosa, and binge eating disorder are reviewed.
Anorexia nervosa
Anorexia nervosa in adults is often persistent in course [1 & ], and no one specialist treatment has been shown to be superior [2 & ], with results primarily focused on short-term findings.
Cognitive behavioral therapy (CBT; targeting the distorted thoughts and maladaptive behaviors that maintain eating disorder symptoms) and interpersonal psychotherapy (IPT; targeting the interpersonal difficulties that maintain eating disorder symptoms) are specialist psychological treatments that address anorexia nervosa symptomatology. The efficacy of CBT and IPT for adults with anorexia nervosa was evaluated against a comparison treatment, specialist supportive clinical management (SSCM; an eating disorder education intervention focused on weight restoration) in a randomized controlled trial (RCT). Long-term findings revealed that 49% of patients evidenced a good outcome (i.e. minimal to no anorexia nervosa symptoms), but no treatment emerged as most efficacious [3] . Across follow-up, the percentage of patients with good outcome remained stable with CBT (41%), improved with IPT (64%), and declined with SSCM (42%). Results from the trial suggest that further evaluation using a stepped-care approach may be warranted, to evaluate whether providing a treatment focused on targeting eating disorder features and restoring weight (e.g., SSCM) and then providing a treatment focused on factors that maintain the disorder in a broader context (e.g., IPT) is advantageous [3] .
Given high rates of nonresponse to specialty treatments, Maudsley Model of Treatment for Adults with Anorexia Nervosa (MANTRA) was developed based on a maintenance model of anorexia nervosa, aimed at addressing cognitive distortions about the utility of anorexia nervosa and rigidity, socio-emotional deficits, and parents'/partners' enabling behaviours. MANTRA was evaluated against SSCM in a RCT [4] . MANTRA and SSCM yielded symptom improvements, and the proportion of patients with global Eating Disorder Examination (EDE) scores within 1 standard deviation (SD) of the community mean (below 1.74) at 12-month followup was 59% in MANTRA and 73% in SSCM; however, across outcomes, the two conditions were not significantly different [4] . A large-scale trial of MANTRA and SSCM is underway to evaluate the long-term comparative efficacy of these treatments (given that SSCM effects decline over time [3] ), subgroup analyses, and cost-effectiveness
Taken together, these data suggest that patients improve with specialty treatments, but a subset remain symptomatic, warranting novel approaches to improve rates of anorexia nervosa symptom remission and increase the rapidity of treatment response. Cognitive remediation therapy (CRT) addresses the impaired cognition that may contribute to the maintenance of anorexia nervosa and may reduce dropout and improve outcomes through increased treatment engagement and improved cognitive flexibility [6 && ]. CRT literature in adults has focused on small case series [6 && ,7,8], and a small RCT did not demonstrate the added benefit of including CRT prior to CBT (although improvements in cognitive functioning were greater in the CRT þ CBT condition), but suggested that investigation of CRT in RCTs is feasible [9]. Continued investigation of CRT is needed with more adequately powered studies, given its preliminary evidence of improved cognitive functioning and patient acceptability [6 && ,9]. Among patients with severe and enduring anorexia nervosa, treatments that focus on recovery may not match patients' readiness to improve and can result in dropout [10 & ]. A novel approach for this population may be to focus on improving treatment retention and quality of life rather than on eating disorder recovery [10 & ]. A RCT was conducted among women with severe and enduring anorexia nervosa (defined as 7 years) using CBT for anorexia nervosa (CBT-AN) and SSCM, adapted such that the primary focus of both treatments was on improving quality of life but not weight gain specifically [10 & ]. Health-related quality of life and eating disorder outcomes improved in both conditions, but at follow-up CBT-AN had better social adjustment, eating disorder symptoms, and readiness to change. Further, 87% completed treatment and 85% completed follow-up assessments, representing the highest retention rate of any treatment trial of adults with anorexia nervosa [ 
Recent updates
Despite the equivalent efficacy of IPT to CBT, the time course for IPT has been shown to be slower than CBT [12] . However, it has been noted that various implementations of IPT may have
KEY POINTS
Though no one specialist treatment has been shown to be superior for treatment of adults with anorexia nervosa, a considerable number of patients improve with specialist psychological treatments.
Cognitive behavioral therapy and interpersonal psychotherapy remain most efficacious for treatment of adults with bulimia nervosa, and treatment delivered in a stepped-care approach may be promising.
Long-term efficacy has been established for cognitive behavioral therapy and interpersonal psychotherapy for treatment of adults with binge eating disorder.
Maudsley family-based therapy is the most established treatment for youth with anorexia nervosa and may be efficacious for youth with bulimia nervosa; interpersonal psychotherapy for the prevention of excess weight gain may be efficacious for reducing loss of control eating and weight gain in overweight adolescents.
Efforts to improve the potency (by targeting key maintaining factors) and expand the implementation of evidence-based treatments (by scaling treatments for widespread delivery) are critical.
attenuated therapeutic effects by failing to discuss eating disorder symptoms (and link them to interpersonal contexts) or by removing IPT techniques that overlap with CBT [15, 16] . IPT has since been modified for clinical use (i.e., IPT-BNm) to more comprehensively address bulimic eating disorders (i.e., bulimia nervosa, binge eating disorder, and subclinical eating disorders with bulimic features), with preliminary efficacy in a pilot case series [16] . Given demands for time-limited therapies, IPT-BNm was subsequently modified to a brief, 10-session delivery format (IPT-BN10) [17] . Thirty patients with bulimic disorders were randomized into IPT-BN10, IPT-BNm, or wait-list control. IPT-BN10 and IPT-BNm outcomes did not differ but were better than wait-list control, suggesting that IPT-BN10 may be feasible and warrants additional study [17] . Given that efficacious specialty treatments are not being implemented in routine practice, a stepped-care trial was conducted to evaluate whether efficacious treatments that do not require specialist care can be used in a stepped-care sequence, potentially increasing ease of dissemination. A stepped-care group ('stepped-care'; consisting of assisted self-help followed by adjunctive fluoxetine and then CBT) was compared with a CBT group ('CBT'; consisting of CBT followed by adjunctive fluoxetine) in a RCT [18] . Remission rates did not significantly differ at 1-year follow-up (32% for stepped-care; 44% for CBT), but stepped-care was more efficacious than CBT in reducing binge eating and compensatory behaviors. Among those predicted as nonresponders, abstinence rates were higher in stepped-care (25%) than CBT (4%) [18] .
Stepped-care was more cost-effective than CBT [19] . Results indicate that, if used in a stepped-care sequence, assisted self-help may be a possible alternative to CBT, and that stepped-care may be an effective approach among patients predicted as nonresponders [18] . Further evaluation of steppedcare order and patient profiles for whom specific components are effective are next steps.
Integrative cognitive-affective therapy (ICAT) for bulimia nervosa aims to enhance treatment efficacy by addressing eating disorder maintaining factors, specifically emotion, self-oriented cognition, and nutritional rehabilitation [20 & ]. ICAT was compared with an enhanced version of CBT (CBT-E; see 'Transdiagnostic treatment for eating disorders' section below). Symptoms improved, but treatments were not significantly different in terms of bingepurge abstinence rates (32.5% for ICAT; 22.5% for CBT-E) and percentage of patients with global EDE scores within 1 SD of the community mean (below 1.74; 55.0% for ICAT; 50.0% for CBT-E) at 4-month follow-up [20 & ]. Further evaluation of ICAT, including assessment of long-term outcomes, is warranted.
Binge eating disorder
CBT and IPT are efficacious for binge eating disorder, with greater results than behavioral weight loss (BWL) [ Recent updates IPT and CBT have been shown to be efficacious at 1 and 2-year follow-up. To extend these findings and evaluate the stability of treatment effects, 5-year outcomes were examined [23 && ]. Results showed CBT and IPT were similarly efficacious in long-term recovery rates (i.e., no objective binge episodes: 52.0% for CBT and 76.7% for IPT). The treatments did not differ from one another at any time point, suggesting both IPT and CBT are efficacious treatments for binge eating disorder [23 && ]. Long-term outcomes of CBT compared with fluoxetine and CBT þ fluoxetine indicated that CBT (i.e., CBT þ fluoxetine and CBT þ placebo), but not fluoxetine, resulted in sustained effects on remission from binge eating (45.5% for CBT þ placebo, 36.8% for CBT þ fluoxetine, and 5.9% for fluoxetine) [25 & ]. Thus, CBT was more effective than fluoxetine, and adjunctive fluoxetine did not add benefit to CBT. Further investigation of patient profiles that predict long-term response to CBT is warranted.
Transdiagnostic treatment for eating disorders
Expanding treatment to more broadly address features that maintain eating disorders may improve symptoms among nonresponders [26] . Moreover, because eating disorders share psychopathology and patients often cross over between diagnoses, a treatment that is applicable for all eating disorders may enhance the scalability of outpatient specialist treatments [26] . For these reasons, CBT was enhanced into a transdiagnostic treatment (i.e., CBT-E) [27] .
Recent updates
CBT-E has demonstrated improvements in patients with BMI >17.5 in an efficacy RCT with 60-week follow-up and an effectiveness open trial evaluating post-treatment outcomes [27, 28] . To evaluate CBT-E specifically among patients at low weight, outpatients with BMI 17.5 were treated with CBT-E [29 & ]. Two-thirds of patients completed treatment, of whom 62% achieved a BMI 18.5 and 88% had a global EDE score within 1 SD of the community mean (below 2.77). Effects slightly deteriorated by 60-week follow-up (55% had a BMI 18.5 and 78% had global EDE scores within 1 SD of the community mean) [29 & ]. Evaluating CBT-E against comparison treatments in RCTs is indicated. ]. Large-scale RCTs evaluating the efficacy of DBT, particularly in comparison to specialist treatment, are warranted. Motivational interviewing interventions have been used to increase retention, given high dropout in eating disorder trials [34] . However, reviews of motivational interviewing suggest it is not well supported for eating disorder treatment [35, 36, 37 && ].
Additional treatments for eating disorders in adults

TREATMENT FOR YOUTH
Intervening with youth represents an ideal target, as eating disorders typically onset in adolescence and treatments can capitalize on parental/family involvement [38] . Maudsley family-based therapy (FBT) is the most established treatment for youth with anorexia nervosa (50% remission rate, defined as normal weight and normal EDE scores) and may be efficacious for youth with bulimia nervosa (approximately 30% remission rate, defined as no binge or purge episodes) [39 & ,40 & ], although it is important to identify treatments for adolescents who do not respond to FBT, as no such treatment currently exists [41] . Given the relation between binge eating, excess weight/obesity, and depression [42 && ], IPT has been adapted for the prevention of excess weight gain (IPT-WG). This treatment resulted in reduced loss of control eating and weight gain in overweight adolescents in a pilot trial [43] , and a large-scale study is underway.
Recent updates
Maudsley FBT was compared with individual adolescent focused therapy (AFT), and recent moderator analyses suggest that patients with more severe psychopathology demonstrated greater remission (95% ideal body weight and scores within 1 SD of EDE global norms) in FBT at the end of treatment, whereas patients with anorexia nervosa binge/purge type had better remission in FBT at 6 and 12-month follow-up [44 & ]. In addition, family therapy focused on intra-familial dynamics (rather than eating disorder symptom-focused, behaviorally oriented FBT) was evaluated as an adjunctive intervention to treatment as usual (TAU) [ 
Maximizing treatment potency
Honing our understanding of the factors that maintain eating disorders and predict patient treatment response may inform development of novel treatment targets. Examining moderators and mediators can be useful for determining for whom and how treatments are most effective. The Research Domain Criteria (RDoC) project aims to bridge neuroscience and genetics to inform diagnostic classification and clinical management [53] . RDoC may be a useful framework for eating disorders and is currently being applied to treatment for binge eating disorder/pediatric disinhibited eating through examination of genetics, appetitive hormones, and brain imaging that may be involved in the onset and maintenance of the disorder and contribute to heterogeneous symptom presentations [ 
Maximizing treatment implementation
Scaling efficacious treatments for widespread implementation is a priority, as the need for treatment far outweighs the availability of resources to deliver evidence-based care [52,58 && ]. Treatments must be designed, adapted, and evaluated for their ability to be disseminated and implemented across multiple settings, as the research settings in which most treatments are developed often differ from routine care settings in which treatments are delivered [52] .
Partnering with stakeholders to evaluate the uptake, cost-effectiveness, and sustainability of evidence-based treatments is critical [59] , as is building capacity among existing front-line service providers to deliver early eating disorder screening and treatment ] may also increase eating disorder identification and care delivery, as they rely less on specialists and are therefore more scalable than specialty approaches. Another advantage to these treatments is the potential for integration within stepped-care, population-based delivery models, resulting in comprehensive systems for care delivery that conserve specialist resources for those most in need [67 && ]. Critical future directions to evaluate GSH and technology-based approaches include evaluating opportunities to enhance the effectiveness and implement GSH treatment, determining optimal levels of training/ expertise for GSH providers, and examining the efficacy, effectiveness, and cost-effectiveness of technology-based treatments [63
CONCLUSION
The eating disorder field continues to hone psychological treatments, but evaluating long-term outcomes and identifying treatments for the subset of patients who remain symptomatic represent critical future directions. Continued efforts to incorporate novel technologies into treatments and effectively train, disseminate, and implement eating disorder treatments will increase access to evidence-based care, thereby reducing the burden of eating disorders.
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